Cantor Fitzgerald has recently initiated Sellas Life Sciences Group Inc (SLS) stock to Overweight rating, as announced on July 21, 2021, according to Finviz. Earlier, on November 1, 2018, Oppenheimer ...
On Wednesday, Sellas Life Sciences Group Inc (SLS) stock saw a decline, ending the day at $1.17 which represents a decrease of $-0.03 or -2.50% from the prior close of $1.2. The stock opened at $1.24 ...
(RTTNews) - Sellas Life Sciences Group, Inc. (SLS), Wednesday announced positive data from preclinical studies identifying ASXL1 mutation as key predictor of SLS009, a highly selective CDK9 inhibitor, ...
Some results have been hidden because they may be inaccessible to you